Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Exploratory Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

NCT07193615 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07193615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Exploratory Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 18, 2025
Completion date
March 31, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1 antitrypsin deficiency (aatd)